inS3-54-A26
CAS No. 328998-77-2
inS3-54-A26 ( —— )
Catalog No. M27885 CAS No. 328998-77-2
inS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 264 | Get Quote |
|
5MG | 402 | Get Quote |
|
10MG | 593 | Get Quote |
|
25MG | 888 | Get Quote |
|
50MG | 1242 | Get Quote |
|
100MG | 1701 | Get Quote |
|
500MG | 3411 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameinS3-54-A26
-
NoteResearch use only, not for human use.
-
Brief DescriptioninS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
DescriptioninS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorERβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number328998-77-2
-
Formula Weight414.9
-
Molecular FormulaC25H19ClN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)Nc1ccc(cc1)N1C(=O)\C(=C/c2ccc(Cl)cc2)C=C1c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang X, et al. Total Synthesis of (+)-Medicarpin. J Nat Prod. 2017 Dec 22;80(12):3284-3288.
molnova catalog
related products
-
8-CHLOROQUINAZOLIN-4...
8-CHLOROQUINAZOLIN-4(1H)-ONE is inhibitor of Poly [ADP-ribose] polymerase 1 (human).
-
Flecainide hydrochlo...
Flecainide is a medication used to prevent and treat abnormally fast heart rates.?This includes ventricular and supraventricular tachycardias.
-
3-Epiursolic acid
3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.